AXQ Capital LP Sells 2,941 Shares of DaVita Inc. (NYSE:DVA)

AXQ Capital LP lessened its stake in DaVita Inc. (NYSE:DVA) by 42.9% during the 4th quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The firm owned 3,921 shares of the company’s stock after selling 2,941 shares during the period. AXQ Capital LP’s holdings in DaVita were worth $586,000 as of its most recent SEC filing.

Other institutional investors and hedge funds also recently added to or reduced their stakes in the company. SBI Securities Co. Ltd. purchased a new position in shares of DaVita during the fourth quarter worth approximately $41,000. Quarry LP bought a new position in DaVita in the third quarter worth approximately $60,000. Venturi Wealth Management LLC increased its holdings in DaVita by 59.8% during the 4th quarter. Venturi Wealth Management LLC now owns 406 shares of the company’s stock worth $61,000 after purchasing an additional 152 shares during the period. Versant Capital Management Inc raised its position in DaVita by 58.7% during the 4th quarter. Versant Capital Management Inc now owns 457 shares of the company’s stock valued at $68,000 after purchasing an additional 169 shares in the last quarter. Finally, Blue Trust Inc. lifted its holdings in shares of DaVita by 39.7% in the 4th quarter. Blue Trust Inc. now owns 461 shares of the company’s stock worth $76,000 after buying an additional 131 shares during the period. Institutional investors own 90.12% of the company’s stock.

Analyst Upgrades and Downgrades

DVA has been the subject of several recent research reports. Sanford C. Bernstein set a $184.00 price objective on DaVita in a report on Friday, February 21st. Cowen restated a “hold” rating on shares of DaVita in a report on Tuesday, February 18th. Barclays upped their price target on shares of DaVita from $164.00 to $169.00 and gave the stock an “equal weight” rating in a research report on Tuesday, February 18th. Finally, StockNews.com downgraded shares of DaVita from a “buy” rating to a “hold” rating in a research note on Friday. One research analyst has rated the stock with a sell rating, five have assigned a hold rating and one has given a buy rating to the stock. According to data from MarketBeat, the stock presently has an average rating of “Hold” and an average target price of $166.33.

DaVita Stock Performance

Shares of DVA opened at $148.25 on Friday. DaVita Inc. has a 12 month low of $125.64 and a 12 month high of $179.60. The stock has a fifty day moving average price of $158.53 and a 200-day moving average price of $157.51. The company has a current ratio of 1.26, a quick ratio of 1.21 and a debt-to-equity ratio of 23.18. The firm has a market cap of $11.86 billion, a PE ratio of 13.80, a P/E/G ratio of 1.07 and a beta of 0.99.

DaVita (NYSE:DVA) last issued its quarterly earnings results on Thursday, February 13th. The company reported $2.24 earnings per share for the quarter, topping analysts’ consensus estimates of $2.14 by $0.10. DaVita had a return on equity of 115.48% and a net margin of 7.31%. Equities research analysts predict that DaVita Inc. will post 10.76 earnings per share for the current fiscal year.

DaVita Profile

DaVita Inc provides kidney dialysis services for patients suffering from chronic kidney failure in the United States. The company operates kidney dialysis centers and provides related lab services in outpatient dialysis centers. It also offers outpatient, hospital inpatient, and home-based hemodialysis services; operates clinical laboratories that provide routine laboratory tests for dialysis and other physician-prescribed laboratory tests for ESRD patients; and management and administrative services to outpatient dialysis centers.